Willow Biosciences Partners with Kalsec
Willow Biosciences Inc. has formed a noteworthy commercial license and royalty agreement with Kalsec Inc. This collaboration is expected to include milestone payments for the initial research and development efforts, as well as a royalty stream for Willow once a groundbreaking natural ingredient is successfully brought to market.
Details of the Agreement
As part of this partnership, Willow is set to receive milestone payments linked to the completion of pilot and industrial batches. Following this, tiered royalty payments will be based on net worldwide sales after the product launch. Kalsec will take charge of the regulatory, manufacturing, and sales and marketing expenses related to this initiative. This collaboration enables Kalsec to broaden its market presence within a global segment valued at around $200 million.
Timeline and Milestones Ahead
The research and development phase is expected to wrap up soon, with regulatory and scale-up activities continuing into the following year. This framework supports Willow's goal of efficiently moving its innovative technology from research stages to commercial reality.
Insights from Leadership
The enthusiasm surrounding this agreement was shared by Dr. Chris Savile, President & CEO of Willow. He stated, "We are excited to see our technology platform deliver once again, turning another research initiative into real commercial success. Partnering with Kalsec, a leader in natural ingredients, allows us to provide consumers with more sustainable options.”
Kalsec’s Commitment to Sustainability
Dr. Roger Nahas, Chief Innovation Officer at Kalsec, highlighted their dedication to utilizing bioconversion technologies that offer effective and affordable natural solutions. He expressed his eagerness for this partnership with Willow, which reflects a mutual objective of addressing the complex ingredient requirements in the savory food industry.
About Willow Biosciences Inc.
Willow specializes in the development and production of precision fermented functional ingredients that serve the health and wellness, food and beverage, and personal care sectors. With platforms like FutureGrown™ and BioOxi™, Willow is committed to promoting sustainability while facilitating large-scale production. Their esteemed R&D team excels at converting bio-based manufacturing processes into commercially viable products, benefiting both their partners and customers.
Frequently Asked Questions
What is the purpose of the agreement between Willow Biosciences and Kalsec?
The agreement aims to commercialize a natural ingredient while ensuring both companies benefit from milestone payments and royalties on sales.
What does Willow Biosciences produce?
Willow develops precision fermented functional ingredients for health, wellness, food, beverage, and personal care markets.
How will this agreement impact the market for natural ingredients?
This partnership is expected to allow Kalsec to expand its market share within a $200 million global segment, enhancing available natural ingredients in savory foods.
What are the main benefits highlighted by Willow's leadership?
Willow's leadership emphasized the commercial advantages and the opportunity to deliver sustainable, natural products to consumers through this partnership.
What technologies does Willow utilize for production?
Willow utilizes its FutureGrown™ and BioOxi™ platforms for large-scale, sustainable production of functional ingredients.
